期刊文献+

多发性骨髓瘤患者NLR水平与免疫水平、生存时间相关性研究 被引量:3

下载PDF
导出
摘要 目的探究多发性骨髓瘤(MM)患者中性粒细胞与淋巴细胞比值(NLR)水平与免疫水平、生存时间相关。方法选取2017年7月-2020年12月我院收治的初发MM患者及同期体检健康者各50例为研究对象,对比MM患者与健康者NLR水平,分析MM患者NLR水平与免疫水平、生存时间相关性。结果MM患者NLR水平要显著高于健康者(P<0.05);MM患者NLR水平与免疫功能水平呈负相关;MM患者NLR水平与OS呈负相关性。结论MM患者NLR水平越高,患者免疫水平越低;MM患者NLR水平与总生存期呈负相关性,提示NLR水平越高,患者预后越差。
出处 《实验与检验医学》 CAS 2021年第4期783-784,788,共3页 Experimental and Laboratory Medicine
基金 江西省卫健委科技计划项目,编号202140868。
  • 相关文献

参考文献12

二级参考文献75

  • 1王智,马晋平,林建伟,陈创奇,蔡世荣,何裕隆.术前中性粒细胞与淋巴细胞比值与结直肠癌患者预后的关系[J].消化肿瘤杂志(电子版),2011,3(4):246-250. 被引量:17
  • 2George J. Weiner.Rituximab: Mechanism of Action[J]. Seminars in Hematology . 2010 (2)
  • 3Myriam Labelle,Shahinoor Begum,Richard O. Hynes.Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis[J]. Cancer Cell . 2011 (5)
  • 4Youngjoo Lee,Sun Hye Kim,Ji-Youn Han,Heung Tae Kim,Tak Yun,Jin Soo Lee.Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy[J]. Journal of Cancer Research and Clinical Oncology . 2012 (12)
  • 5Weinstock M, Aljawai Y, Morgan EA, et al. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation[J]. Br J Haematol, 2015, 169(6):851-858.
  • 6Bladé J, de Larrea CF, Rosi?ol L. Extramedullary involvement in multiple myeloma[J]. Haematologica, 2012, 97(11):1618-1619.
  • 7Wang F, Liu ZY, Xia YY, et al. Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer[J]. Oncol Lett, 2015, 10(6):3411-3418.
  • 8Yodying H, Matsuda A, Miyashita M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer:a systematic review and meta-analysis[J]. Ann Surg Oncol, 2016, 23(2):646-654.
  • 9International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders:a report of the International Myeloma Working Group[J]. Br J Haematol, 2003, 121(5):749-757.
  • 10Bladé J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant[J]. Br J Haematol, 1998, 102(5):1115-1123.

共引文献103

同被引文献34

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部